JPH027318B2 - - Google Patents
Info
- Publication number
- JPH027318B2 JPH027318B2 JP16961382A JP16961382A JPH027318B2 JP H027318 B2 JPH027318 B2 JP H027318B2 JP 16961382 A JP16961382 A JP 16961382A JP 16961382 A JP16961382 A JP 16961382A JP H027318 B2 JPH027318 B2 JP H027318B2
- Authority
- JP
- Japan
- Prior art keywords
- inosine
- reaction
- formula
- general formula
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229930010555 Inosine Natural products 0.000 claims description 21
- 229960003786 inosine Drugs 0.000 claims description 21
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 claims description 20
- -1 thionyl halide Chemical class 0.000 claims description 14
- 239000000126 substance Substances 0.000 claims description 8
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Natural products SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 5
- 239000004201 L-cysteine Substances 0.000 claims description 5
- 235000013878 L-cysteine Nutrition 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 150000001340 alkali metals Chemical group 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 description 22
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 239000013078 crystal Substances 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 238000003756 stirring Methods 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- 239000011541 reaction mixture Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000001816 cooling Methods 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 8
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 8
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 7
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 230000000704 physical effect Effects 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 229960002433 cysteine Drugs 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 125000006239 protecting group Chemical group 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 2
- 239000004158 L-cystine Substances 0.000 description 2
- 235000019393 L-cystine Nutrition 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000001118 alkylidene group Chemical group 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 229960003067 cystine Drugs 0.000 description 2
- SAEXFNRQXFBCIC-NVKWYWNSSA-L disodium;(2r)-2-amino-3-sulfanylpropanoate Chemical compound [Na+].[Na+].SC[C@H](N)C([O-])=O.SC[C@H](N)C([O-])=O SAEXFNRQXFBCIC-NVKWYWNSSA-L 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- HFRXJVQOXRXOPP-UHFFFAOYSA-N thionyl bromide Chemical compound BrS(Br)=O HFRXJVQOXRXOPP-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- VLSOAXRVHARBEQ-UHFFFAOYSA-N [4-fluoro-2-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=C(F)C=C1CO VLSOAXRVHARBEQ-UHFFFAOYSA-N 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- OEERIBPGRSLGEK-UHFFFAOYSA-N carbon dioxide;methanol Chemical compound OC.O=C=O OEERIBPGRSLGEK-UHFFFAOYSA-N 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical group O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
Landscapes
- Saccharide Compounds (AREA)
Description
【発明の詳細な説明】
本発明は、式、
で表わされるイノシン誘導体の新規な製造方法に
関する。DETAILED DESCRIPTION OF THE INVENTION The present invention is based on the formula: This invention relates to a novel method for producing an inosine derivative represented by:
式(1)の化合物は、米国特許第4011221号明細書
に記載されており、公知の物質であるが、この物
質は、細胞増殖作用を有し、組織障害に基づく疾
患の治療等に優れた効果を有する医薬品として有
用な化合物である。 The compound of formula (1) is described in U.S. Patent No. 4,011,221 and is a well-known substance, which has a cell proliferation effect and is excellent in the treatment of diseases caused by tissue damage. It is a compound useful as an effective medicine.
式(1)の化合物の製法としては、上記米国特許明
細書に記載されている方法が知られているが、こ
の米国特許記載の方法は次の図式で示される如き
ものである。 As a method for producing the compound of formula (1), the method described in the above-mentioned US patent specification is known, and the method described in this US patent is as shown in the following scheme.
(式中、Rはヒポキサンチン残基、Cystはシス
テイン残基であり、R1、R2は低級アルキル基又
はアリール基である)
すなわち、上記の公知方法においては、イノシ
ンを出発物質として用いるときは、5′−位にシス
テイン残基を導入するに先立つて、イノシンの
2′,3′−位をアルキリデン基等に替えて予め保護
しておき(保護化工程)、所望の反応を行つた後、
保護基である前記の2′,3′−位のアルキリデン基
等を脱離せしめて(保護基の脱離工程)、式()
の化合物を製造するというものである。かかる公
知方法は、上記式中のイノシンの2′,3′−位を、
一旦、保護基の導入により保護する保護化工程と
反応後に行う保護基の脱離工程とを必要とする点
で、迂遠な方法である。 (In the formula, R is a hypoxanthine residue, Cyst is a cysteine residue, and R 1 and R 2 are lower alkyl groups or aryl groups.) That is, in the above known method, when inosine is used as a starting material, In this method, prior to introducing a cysteine residue at the 5′-position, inosine
The 2′ and 3′-positions are protected in advance by replacing them with alkylidene groups, etc. (protection step), and after performing the desired reaction,
By removing the protective groups such as alkylidene groups at the 2' and 3' positions (protecting group removal step), the formula () is obtained.
The aim is to produce a compound of In this known method, the 2', 3'-positions of inosine in the above formula are replaced by
This is a roundabout method in that it requires a protection step in which protection is once introduced by introducing a protecting group and a step in which the protecting group is removed after the reaction.
本発明者らは、式()の化合物の改良製法に
ついて鋭意研究した結果、イノシンの2′,3′−位
を特段に保護することなく、そのままハロゲン化
チオニルで処理すると、新規な5′−ハロゲノ−
5′−デオキシ−2′,3′−O−スルフイニルイノシ
ンが得られることおよびこの新規物質を用いて効
率良く式(1)の化合物が製造できることを見い出し
た。本発明はかかる知見に基づいてなされたもの
である。 As a result of intensive research into an improved method for producing the compound of formula (), the present inventors found that when inosine is directly treated with thionyl halide without special protection at the 2' and 3' positions, a novel 5'- Halogeno
It has been discovered that 5'-deoxy-2',3'-O-sulfinyl inosine can be obtained and that the compound of formula (1) can be efficiently produced using this new substance. The present invention has been made based on this knowledge.
すなわち本発明は、イノシンとハロゲン化チオ
ニルとを反応させて得られる一般式
(式中、Xはハロゲン原子を示す)
で表わされるイノシノハロゲン誘導体を、必要に
応じて、塩基物質で処理した後、一般式
(式中、Mは水素原子又はアルカリ金属原子を示
す)
で表わされるL−システイン化合物と反応させる
ことを特徴とする式()で表わされるイノシン
誘導体を製造する新規な方法を提供するものであ
る。 That is, the present invention provides a general formula obtained by reacting inosine with a thionyl halide. (In the formula, X represents a halogen atom) After treating the inosinohalogen derivative represented by the general formula with a basic substance as necessary, (In the formula, M represents a hydrogen atom or an alkali metal atom) .
本発明により、イノシンを出発物質として用
い、その2′,3′−位を予め特段に保護することな
く、5′−位に反応活性に富むハロゲンを有する化
合物、すなわち、5′−ハロゲノ−5′−デオキシ−
2′,3′−O−スルフイニルイノシンが得られ、こ
れを直ちに次の反応により5′−位にシステイン残
基を有する式()の目的化合物に変換すること
ができるので、本発明の方法は、工程数が少な
く、かつ処理操作が簡便であるという点で極めて
製造効率の優れた方法である。 According to the present invention, inosine is used as a starting material, and a compound having a highly reactive halogen at the 5'-position, that is, 5'-halogeno-5 ′-deoxy-
2',3'-O-sulfininylinosine is obtained, which can be immediately converted into the target compound of formula () having a cysteine residue at the 5'-position by the following reaction, and therefore the present invention This method has extremely high production efficiency in that the number of steps is small and processing operations are simple.
上記の一般式()で表わされるイノシノハロ
ゲン誘導体は、イノシンとハロゲン化チオニルと
を反応させることにより製造されるところ、この
場合のハロゲン化チオニルのハロゲンとしては塩
素又は臭素を挙げることができ、ハロゲン化チオ
ニルとして塩化チオニルを用いるときは、イノシ
ノクロル誘導体が得られ、また臭化チオニルを用
いるときは、イノシノブロム誘導体が得られる。 The inosinohalogen derivative represented by the above general formula () is produced by reacting inosine with a thionyl halide, and in this case, the halogen of the thionyl halide can include chlorine or bromine, When thionyl chloride is used as the thionyl halide, an inosinochlor derivative is obtained, and when thionyl bromide is used, an inosinobrome derivative is obtained.
上記の反応は、通常、ピリジン又はヘキサメチ
ルホスホリツクアミド等の極性有機溶媒中で、10
〜40℃、好ましくは10〜20℃の温度で、0.5〜2
時間行うのが好都合である。また、ハロゲン化チ
オニルの使用量は原料のイノシン1モルに対し、
5〜7倍モル量程度である。かくして得られた反
応混合物を撹拌下に、氷水中に注ぎ、必要に応じ
て重炭酸ナトリウム、重炭酸カリウム等の弱塩基
物質を加えることによつて、未反応のハロゲン化
チオニルを分解し、次いでこの溶液を冷却するこ
とによつて、一般式()で表わされるイノシノ
ハロゲン誘導体が結晶として得られる。こうして
得られるイノシノハロゲン誘導体を一旦単離し、
あるいは単離することなく、必要に応じて、塩基
物質で処理した後、一般式()で表わされるL
−システイン化合物と反応させることにより一般
式()で表わされるイノシン誘導体が製造され
る。 The above reaction is usually carried out in a polar organic solvent such as pyridine or hexamethylphosphoricamide for 10
0.5-2 at a temperature of ~40℃, preferably 10-20℃
It is convenient to do it on time. In addition, the amount of thionyl halide used per mole of inosine as the raw material is
It is about 5 to 7 times the molar amount. The reaction mixture thus obtained is poured into ice water under stirring, unreacted thionyl halide is decomposed by adding a weak basic substance such as sodium bicarbonate, potassium bicarbonate, etc. as necessary, and then By cooling this solution, an inosinohalogen derivative represented by the general formula () is obtained as a crystal. The inosinohalogen derivative obtained in this way is once isolated,
Alternatively, without isolation, if necessary, after treatment with a basic substance, L represented by the general formula ()
- An inosine derivative represented by the general formula () is produced by reacting with a cysteine compound.
一般式()で表わされるイノシノハロゲン誘
導体と一般式()で表わされるL−システイン
化合物とを反応させる場合には、溶媒としてメタ
ノール等のアルコール類、ジメチルホルムアミ
ド、水等を単独に又はこれらの混合溶媒として用
いて、室温ないし100℃の温度で10時間〜2日間
反応させるのが好都合である。また、一般式
()で表わされるL−システイン化合物の使用
量比は、ハロゲノイノシン誘導体1モルに対し、
2倍モル以上、好ましくは2〜4倍モルである。 When reacting the inosinohalogen derivative represented by the general formula () with the L-cysteine compound represented by the general formula (), alcohols such as methanol, dimethylformamide, water, etc. may be used alone or in combination with these solvents. It is convenient to use a mixed solvent and carry out the reaction at a temperature of room temperature to 100°C for 10 hours to 2 days. In addition, the usage ratio of the L-cysteine compound represented by the general formula () to 1 mole of the halogenoinosine derivative is:
The amount is 2 times the mole or more, preferably 2 to 4 times the mole.
反応混合物は、そのまま又は一旦析出結晶を
取した後、水に溶解した後、濃塩酸等で中和し、
次いで冷却し析出する結晶を取することにより
式()で表わされるイノシン誘導体を得る。 The reaction mixture is dissolved in water as it is or after removing the precipitated crystals, neutralized with concentrated hydrochloric acid, etc.
Then, the inosine derivative represented by the formula () is obtained by cooling and collecting the precipitated crystals.
イノシノハロゲン誘導体を塩基物質で処理する
場合には、塩基物質として水酸化ナトリウム、水
酸化カリウム水溶液を用いて、室温下に、5〜10
分反応させるのが好都合であり、次いで反応混合
物を塩酸等の鉱酸で中和し、析出物を分取する。
このものは再結晶するか又はすることなく次の反
応に付することができる。 When treating inosinohalogen derivatives with a basic substance, use an aqueous solution of sodium hydroxide or potassium hydroxide as the basic substance,
It is convenient to carry out the reaction in fractions, then the reaction mixture is neutralized with a mineral acid such as hydrochloric acid and the precipitate is separated.
This product can be subjected to the next reaction with or without recrystallization.
このようにして得られる生成物と一般式()
で表わされるL−システイン化合物とを反応させ
る場合には、溶媒として、メタノール等のアルコ
ール類、ジメチルホルムアミド、水等を単独で又
はこれらの混合溶媒として用い、室温ないし還流
下で、3〜8時間反応を行わせるのが好ましい。
溶媒としては、液体アンモニア等も用いることが
できる。この場合には、反応は−40〜−35℃の温
度で10〜15時間行うのが好都合である。一般式
()で表わされるL−システイン化合物の使用
量比はイノシノハロゲン誘導体1モルに対して
1.2倍モル以上、好ましくは2〜3倍モル量程度
である。 The product thus obtained and the general formula ()
When reacting with the L-cysteine compound represented by the following, alcohols such as methanol, dimethylformamide, water, etc. are used as a solvent alone or as a mixed solvent thereof, and the reaction is carried out at room temperature or under reflux for 3 to 8 hours. Preferably, the reaction is carried out.
Liquid ammonia or the like can also be used as the solvent. In this case, the reaction is conveniently carried out at a temperature of -40 DEG to -35 DEG C. for 10 to 15 hours. The usage ratio of the L-cysteine compound represented by the general formula () is based on 1 mole of the inosinohalogen derivative.
The amount is 1.2 times or more by mole or more, preferably about 2 to 3 times by mole.
かくして得られた反応混合物は、そのまま、又
は一旦析出した結晶を取した後、水に溶解し、
濃塩酸等で中和し、冷却し、析出する結晶を取
する。液体アンモニアを溶媒として用いた場合に
は、反応終了後、反応混合物からアンモニアを留
去し、その残留物に水を加えて上記と同様に処理
する。かくして、式()で表わされるイノシン
誘導体が得られる。 The reaction mixture thus obtained is dissolved in water as it is, or after removing the precipitated crystals,
Neutralize with concentrated hydrochloric acid, cool, and remove precipitated crystals. When liquid ammonia is used as a solvent, after the reaction is completed, ammonia is distilled off from the reaction mixture, water is added to the residue, and the same treatment as above is performed. In this way, an inosine derivative represented by formula () is obtained.
次に実施例を挙げて、さらに本発明を説明す
る。 Next, the present invention will be further explained with reference to Examples.
実施例 1
(a) 冷却撹拌下に、塩化チオニル15.5g(0.13モ
ル)をピリジン30mlに加え、この溶液にイノシ
ン5g(0.019モル)を加えて10〜20℃で2時
間反応させる。Example 1 (a) While cooling and stirring, 15.5 g (0.13 mol) of thionyl chloride is added to 30 ml of pyridine, and 5 g (0.019 mol) of inosine is added to this solution, followed by reaction at 10-20°C for 2 hours.
反応終了後、反応混合物を氷水中に注ぎ込
み、撹拌下に放置する。これを冷却し、生成し
た析出結晶を取し、少量の冷水で洗浄した
後、乾燥すると、5.3gの5′−クロル−5′−デオ
キシ−2′,3′−O−スルフイニルイノシン(収
率84%)が粉末結晶として得られた。このもの
は融点202.5〜205℃(分解)を示す。 After the reaction is complete, the reaction mixture is poured into ice water and left under stirring. After cooling, the precipitated crystals were collected, washed with a small amount of cold water, and dried. (Yield: 84%) was obtained as a powder crystal. This material has a melting point of 202.5-205°C (decomposed).
Rf値0.65(展開溶媒クロロホルム:メタノール
=35:10)
元素分析値 C10H9N4O5SCl
計算値:C、36.10:H、2.73:N、16.87:
S、9.64:Cl、10.65
実測値(%):C、36.16:H、2.69:N、
16.73: S、9.65:Cl、10.39
(b) 室温下に、150mlの1規定の水酸化ナトリウ
ム水溶液中に、上記の5′−クロル−5′−デオキ
シ−2′,3′−O−スルフイニルイノシン15gを
加え、10分間撹拌する。反応終了後、反応溶液
に濃塩酸を撹拌下に加えて中和し、冷却下に反
応混合物を放置し、析出する結晶を取し、次
いで、水洗乾燥すると、12.4gの結晶生成物が
得られた。 R f value 0.65 (Developing solvent chloroform: methanol = 35:10) Elemental analysis value C 10 H 9 N 4 O 5 SCl Calculated value: C, 36.10: H, 2.73: N, 16.87:
S, 9.64: Cl, 10.65 Actual value (%): C, 36.16: H, 2.69: N,
16.73: S, 9.65: Cl, 10.39 (b) The above 5'-chloro-5'-deoxy-2',3'-O-sulfuric acid was added to 150 ml of 1 N aqueous sodium hydroxide solution at room temperature. Add 15 g of nyl inosine and stir for 10 minutes. After the reaction was completed, concentrated hydrochloric acid was added to the reaction solution under stirring to neutralize it, the reaction mixture was left to cool, and the precipitated crystals were collected, then washed with water and dried to obtain 12.4 g of crystalline product. Ta.
(c) この結晶生成物12g及びL−システイン塩酸
塩14.5g(0.092モル)を6.7gの金属ナトリウ
ムを溶解した120mlのメタノール溶液に加え、
8時間加熱還流する。反応終了後、この反応混
合物に60mlのメタノールと少量の水を加えて、
不溶物を溶解し、冷却撹拌下に濃塩酸で中和す
る。次いで、この混合溶液を冷却下に放置し、
析出結晶を取する。これを水から再結晶する
と、6.2g(40%)の無色結晶のS−イノシル
システインが得られた。この物の紫外線吸収ス
ペクトルは、λH2O nax=249mμ(εnax=1.30×104)
を示し、施光度は〔α〕27.40 D=+11.2゜(C=1、
H2O)を示した。(c) 12 g of this crystalline product and 14.5 g (0.092 mol) of L-cysteine hydrochloride were added to 120 ml of methanol solution in which 6.7 g of sodium metal was dissolved;
Heat to reflux for 8 hours. After the reaction is complete, add 60ml of methanol and a small amount of water to the reaction mixture.
Insoluble matter is dissolved and neutralized with concentrated hydrochloric acid while stirring while cooling. Then, this mixed solution was left under cooling,
Take the precipitated crystals. When this was recrystallized from water, 6.2 g (40%) of colorless crystals of S-inosylcysteine were obtained. The ultraviolet absorption spectrum of this object is λ H2O nax = 249 mμ (ε nax = 1.30×10 4 )
, and the light intensity is [α] 27.40 D = +11.2° (C = 1,
H2O ).
実施例 2
(a) 冷却撹拌下に、塩化チオニル19g(0.16モ
ル)をピリジン40mlに加え、この溶液にイノシ
ン6.5g(0.024モル)を加えて、35〜40℃で0.5
時間反応させる。反応終了後、実施例1(a)と同
様に処理すると、6.5gの5′−クロル−5′−デオ
キシ−2′,3′−O−スルフイニルイノシン(収
率81%)が粉末結晶として得られた。このもの
の物性値は実施例1(a)で得たものの物性値と一
致した。Example 2 (a) Add 19 g (0.16 mol) of thionyl chloride to 40 ml of pyridine under cooling stirring, add 6.5 g (0.024 mol) of inosine to this solution, and add 0.5 g (0.024 mol) of inosine at 35-40°C.
Allow time to react. After the reaction was completed, the same procedure as in Example 1(a) was carried out to obtain 6.5 g of 5'-chloro-5'-deoxy-2',3'-O-sulfinyl inosine (yield 81%) as powder crystals. obtained as. The physical properties of this product were consistent with those obtained in Example 1(a).
(b) ジメチルホルムアミド30mlに、上記の5′−ク
ロル−5′−デオキシ−2′,3′−O−スルフイニ
ルイノシン2gとL−システインジナトリウム
塩3gとを加え、室温撹拌下に24時間反応させ
る。反応終了後、反応混合物を冷却下に放置
し、析出する結晶を取し、少量のジメチルホ
ルムアミドで洗浄し、次いでエタノールで洗浄
した後、水16mlに溶解し、濃塩酸で中和する。
以下実施例1(c)におけると同様に処理すると、
0.48g(21%)の無色結晶のS−イノシルシス
テインが得られた。このものの物性値は実施例
1(c)で得たものの物性値と一致した。(b) Add 2 g of the above 5'-chloro-5'-deoxy-2',3'-O-sulfininylinosine and 3 g of L-cysteine disodium salt to 30 ml of dimethylformamide, and stir at room temperature for 24 hours. Allow time to react. After the reaction is complete, the reaction mixture is left to cool, and the precipitated crystals are collected, washed with a small amount of dimethylformamide, then washed with ethanol, dissolved in 16 ml of water, and neutralized with concentrated hydrochloric acid.
After processing in the same manner as in Example 1(c),
0.48 g (21%) of colorless crystals of S-inosylcysteine were obtained. The physical properties of this product were consistent with those obtained in Example 1(c).
実施例 3
(a) 冷却撹拌下に、塩化チオニル23.7g(0.2モ
ル)をヘキサメチルホスホリツクアミド95mlに
加え、この溶液に、さらにイノシン9.6g
(0.036モル)を撹拌下に加えて15時間撹拌を続
けた。次いで、反応終了後は実施例1(a)におけ
ると同様に反応混合物を処理すると、10.1gの
5′−クロル−5′−デオキシ−2′,3′−O−スル
フイニルイノシン(85%)が粉末結晶として得
られた。このものの物性値は実施例1(a)で得た
ものの物性値と一値した。Example 3 (a) While cooling and stirring, 23.7 g (0.2 mol) of thionyl chloride are added to 95 ml of hexamethylphosphoricamide, and to this solution is further added 9.6 g of inosine.
(0.036 mol) was added under stirring and stirring was continued for 15 hours. After the reaction was completed, the reaction mixture was then treated in the same manner as in Example 1(a), yielding 10.1 g of
5'-chloro-5'-deoxy-2',3'-O-sulfinyl inosine (85%) was obtained as a powder crystal. The physical properties of this product were the same as those obtained in Example 1(a).
(b) 上記(a)で得た5′−クロル−5′−デオキシ−2′
,
3′−O−スルフイニルイノシン2.4gを実施例
1(b)と同様に処理すると結晶生成物2gが得ら
れた。(b) 5′-chloro-5′-deoxy-2′ obtained in (a) above
,
2.4 g of 3'-O-sulfinyl inosine was treated in the same manner as in Example 1(b) to obtain 2 g of crystalline product.
(c) 上記結晶生成物2gをメタノール20mlと水
0.4mlの混合溶媒に懸濁し、これにL−システ
インジナトリウム塩3.45gを加えて、還流下に
5時間反応させる。反応終了後、反応混合物を
実施例1(c)と同様に処理すると、1.2g(45%)
の無色結晶のS−イノシルシステインが得られ
た。このものの物性値は実施例1(c)で得たもの
の物性値と一致した。(c) Add 2 g of the above crystalline product to 20 ml of methanol and water.
The suspension was suspended in 0.4 ml of a mixed solvent, 3.45 g of L-cysteine disodium salt was added thereto, and the mixture was reacted under reflux for 5 hours. After the reaction was completed, the reaction mixture was treated in the same manner as in Example 1(c), yielding 1.2 g (45%)
Colorless crystals of S-inosylcysteine were obtained. The physical properties of this product were consistent with those obtained in Example 1(c).
実施例 4
(a) イノシン25g(0.093モル)をヘキサメチル
ホスホリツクトリアミド250mlに懸濁し、これ
に臭化チオニル40ml(0.52モル)を冷却撹拌下
に滴下する。次いで15時間撹拌を続けた後、反
応液を氷水中に注ぎ込み、実施例1(a)と同様に
処理すると、融点205〜240℃(分解)の5′−ブ
ロム−5′−デオキシ−2′,3′−スルフイニルイ
ノシン17.5g(49.7%)が得られた。Example 4 (a) 25 g (0.093 mol) of inosine is suspended in 250 ml of hexamethylphosphoric triamide, and 40 ml (0.52 mol) of thionyl bromide is added dropwise thereto under stirring while cooling. After stirring for 15 hours, the reaction solution was poured into ice water and treated in the same manner as in Example 1(a) to give 5'-bromo-5'-deoxy-2' with a melting point of 205-240°C (decomposition). , 17.5 g (49.7%) of 3'-sulfinyl inosine were obtained.
Rf0.67(展開溶媒クロロホルム:メタノール=
35:10)
元素分析値 C10H9N4O5SBr
計算値C、31.4;H、2.40;N、14.85;
S、8.50;Br、21.19
実測値C、31.76;H、2.39;N、14.79;
S、8.63;Br、21.34
(b) 上記(a)で得た5′−ブロム−5′−デオキシ−2′
,
3′−O−スルフイニルイノシン15gを実施例1
(b)と同様にして処理して結晶生成物13gを得
た。 R f 0.67 (Developing solvent chloroform: methanol =
35:10) Elemental analysis value C 10 H 9 N 4 O 5 SBr Calculated value C, 31.4; H, 2.40; N, 14.85;
S, 8.50; Br, 21.19 Actual value C, 31.76; H, 2.39; N, 14.79;
S, 8.63; Br, 21.34 (b) 5'-bromo-5'-deoxy-2' obtained in (a) above
,
Example 1: 15 g of 3'-O-sulfinyl inosine
The same procedure as in (b) was carried out to obtain 13 g of crystalline product.
(c) 予め、約1000mlの液体アンモニアを、水酸化
ナトリウムをつめた乾燥管付きのドライアイス
−メタノールで冷却した容器に採り、これに
6.6g(0.027モル)のL−シスチンを加えた
後、溶液の色が微青色になるまで金属ナトリウ
ムを徐々に加える。次いで少量のL−シスチン
を加えて脱色した溶液に、上記(b)で得た結晶生
成物13gを加え、−40〜−35℃で撹拌下に12時
間反応させる。反応終了後、反応混合物を一夜
放置して、アンモニアを蒸発させる。残留物に
水を加えて、これを溶解させた後、冷却下に放
置し析出した結晶を取し、冷水で水洗後乾燥
する。この結晶を水から再結晶すると、S−イ
ノシルシステイン4.9g(33%)が無色結晶と
して得られた。このものの物性値は実施例1(c)
で得たものの物性値と一致した。(c) Pour approximately 1000ml of liquid ammonia into a container filled with sodium hydroxide and cooled with dry ice-methanol and equipped with a drying tube.
After adding 6.6 g (0.027 mol) of L-cystine, sodium metal is gradually added until the solution becomes slightly blue in color. Next, 13 g of the crystalline product obtained in step (b) above is added to the solution that has been decolorized by adding a small amount of L-cystine, and the mixture is reacted at -40 to -35°C with stirring for 12 hours. After the reaction is complete, the reaction mixture is left overnight to evaporate the ammonia. Water is added to the residue to dissolve it, and the mixture is left to cool, and the precipitated crystals are collected, washed with cold water, and then dried. When the crystals were recrystallized from water, 4.9 g (33%) of S-inosylcysteine was obtained as colorless crystals. The physical properties of this product are as shown in Example 1(c)
The physical properties were consistent with those obtained in .
Claims (1)
て得られる一般式 (式中、Xはハロゲン原子を示す) で表わされるイノシノハロゲン誘導体を、必要に
応じて、塩基物質で処理した後、一般式 (式中、Mは水素原子又はアルカリ金属原子を示
す) で表わされるL−システイン化合物と反応させる
ことを特徴とする式、 で表わされるイノシン誘導体の製造方法。[Claims] 1 General formula obtained by reacting inosine and thionyl halide (In the formula, X represents a halogen atom) After treating the inosinohalogen derivative represented by the general formula with a basic substance as necessary, (In the formula, M represents a hydrogen atom or an alkali metal atom) A formula characterized by reacting with an L-cysteine compound represented by: A method for producing an inosine derivative represented by
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16961382A JPS5959699A (en) | 1982-09-30 | 1982-09-30 | Novel preparation of inosine derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16961382A JPS5959699A (en) | 1982-09-30 | 1982-09-30 | Novel preparation of inosine derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5959699A JPS5959699A (en) | 1984-04-05 |
JPH027318B2 true JPH027318B2 (en) | 1990-02-16 |
Family
ID=15889739
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP16961382A Granted JPS5959699A (en) | 1982-09-30 | 1982-09-30 | Novel preparation of inosine derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5959699A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7300923B2 (en) * | 2004-08-30 | 2007-11-27 | Cv Therapeutics, Inc. | Partial and full agonists of A1 adenosine receptors |
-
1982
- 1982-09-30 JP JP16961382A patent/JPS5959699A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS5959699A (en) | 1984-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO783559L (en) | PROCEDURE FOR PREPARING 2,6-DIAMINONE BULARINES | |
JPH027318B2 (en) | ||
AU672533B2 (en) | Process for preparing AZT and derivatives thereof | |
JPS5857373A (en) | Preparation of l-ascorbic acid derivative | |
KR100393913B1 (en) | Method for producing di 4-thiadiene from 5-methyluridine | |
KR910006125B1 (en) | Preparation process of acemetacin | |
JPH027317B2 (en) | ||
JP2007513134A (en) | Improved synthesis of 2-substituted adenosine | |
EP0040418B1 (en) | Process for preparing an 1h-indazol-3-ylacetic acid derivative | |
JP3217541B2 (en) | Method for producing guanine derivative | |
JPS588093A (en) | 5-halogeno-3'-deoxyuridine and its preparation | |
US3751462A (en) | Process for preparation of substituted fluoromethanesulfonanilides | |
US4459415A (en) | Process for the preparation of 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetoxyacetic acid | |
JP4183781B2 (en) | Method for producing S, S- (6-methylquinoxaline-2,3-diyl) dithiocarbonate | |
US1906200A (en) | 4-brom-diethylacetylamino-1-phenyl-2, 3-dimethyl-5-pyrazolone and the process of preparing the same | |
JPS5813594A (en) | Phosphonodipeptide derivative | |
JPS6030669B2 (en) | Production method of hydrazone derivatives | |
JPS6337104B2 (en) | ||
JPS626713B2 (en) | ||
KR100498894B1 (en) | Process for producing 1-chlorocarbonyl-4-piperidino- piperidine or hydrochloride thereof | |
JPH0154359B2 (en) | ||
JP2001226378A (en) | Halogenopurine compound | |
JPS60169470A (en) | Novel phenylpiperazine derivative | |
JPS58140087A (en) | Preparation of n1-phthalidyl-5-fluorouracil | |
JPS59128387A (en) | Manufacture and intermediate of 1'-ethoxycarbonyl oxyethyl ester of penicillin |